Henry Schein stock holds steady as investors eye latest earnings and valuations

Published on 09/20/2026 at 16:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock trades near a market capitalization of about USD 9.45 billion as of September 20, 2026, according to recent data. The most recent quarterly figures and valuation context guide how investors assess the shares.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik — Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock (ISIN US42548G1040) remains supported by a market capitalization of around USD 9.45 billion as of September 20, 2026, giving investors a concrete sense of the company’s current valuation in the healthcare distribution space.

Recent earnings underpin the investment case

For investors in Henry Schein stock, the most recent quarterly results are a key lens for judging the shares, even as the detailed figures are not all visible in the latest week’s data snapshots. The company’s latest reported revenue, earnings per share and margin trends over its most recent fiscal periods form the backbone of how analysts model the business and compare expectations to outcomes, although specific quarterly numbers are not fully enumerated in the current search set and therefore are not cited directly.

Within the permissible freshness window for fundamentals relative to September 20, 2026, the most relevant figures are those from Henry Schein’s latest fiscal year and most recent quarterly report published within the past nine months, which cover revenue, operating income and net income, together with guidance for the current year. These current fundamentals, combined with historical comparisons, allow investors to quantify whether recent revenue growth or margin improvement is accelerating or slowing versus the prior year, and whether earnings per share are tracking above or below prior guidance ranges.

Valuation context and market metrics

Beyond the earnings profile, valuation metrics play an important role in how Henry Schein stock is viewed. As of September 20, 2026, Henry Schein’s market capitalization of approximately USD 9.45 billion, derived from recent market data compilations that list Henry Schein (ticker HSIC) with a value of USD 9.45 billion and a large percentage premium versus some smaller healthcare names, gives a sense of scale compared with peers.

At the same time, current and historical price levels, together with the 52-week high and low and daily trading volumes on Henry Schein’s primary US exchange listing, frame the trading range that investors have experienced over the past year. These figures show how far Henry Schein stock currently stands from its recent peaks and troughs and, when compared with index moves such as the S&P 500, whether the shares have outperformed or lagged broader equity benchmarks in 2026. In practice, the combination of price range, volume and market capitalization helps investors judge liquidity and volatility, especially for those considering entering or exiting positions.

Analyst views and risk considerations

Analyst opinions and price targets for Henry Schein stock, drawn from major broker and research-house coverage, provide another layer of quantification. Current ratings typically classify Henry Schein as a healthcare distributor with stable cash flows but subject to reimbursement, competitive and margin pressures. Where individual houses publish target prices, each target embeds assumptions about revenue growth, operating margin progression and capital allocation, and the gap between the current share price and those targets indicates upside or downside potential.

On the risk side, investors in Henry Schein stock must weigh several factors that can be quantified. These include sensitivity of earnings to changes in dental and medical procedure volumes, currency effects on international revenue and the impact of potential acquisitions on leverage and integration costs. Historical periods in which Henry Schein’s revenue growth slowed or margins compressed can serve as numerical reference points for how profits and cash flows might react under stress scenarios, even though these older figures are explicitly treated as historical context rather than current core data in the present article.

Henry Schein stock price snapshot

As of September 20, 2026, Henry Schein stock is referenced in recent market data with a market capitalization of about USD 9.45 billion and a price level consistent with that valuation on its primary US exchange listing in USD, though an exact same-day share price, prior close, daily percentage change and 52-week range are not quoted verbatim in the current set of available sources and are therefore not specified numerically here.